- Home
- APVO vs OMH Comparison
APVO vs OMH Comparison
Compare APVO & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- OMH
- Stock Information
- Founded
- APVO 2016
- OMH 2015
- Country
- APVO United States
- OMH Singapore
- Employees
- APVO N/A
- OMH N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- OMH Real Estate
- Sector
- APVO Health Care
- OMH Finance
- Exchange
- APVO Nasdaq
- OMH Nasdaq
- Market Cap
- APVO 21.7M
- OMH 25.2M
- IPO Year
- APVO N/A
- OMH 2023
- Fundamental
- Price
- APVO $1.09
- OMH $0.84
- Analyst Decision
- APVO
- OMH Hold
- Analyst Count
- APVO 0
- OMH 1
- Target Price
- APVO N/A
- OMH N/A
- AVG Volume (30 Days)
- APVO 757.7K
- OMH 174.2K
- Earning Date
- APVO 11-06-2025
- OMH 10-30-2025
- Dividend Yield
- APVO N/A
- OMH N/A
- EPS Growth
- APVO N/A
- OMH N/A
- EPS
- APVO N/A
- OMH N/A
- Revenue
- APVO N/A
- OMH $7,976,578.00
- Revenue This Year
- APVO N/A
- OMH $28.40
- Revenue Next Year
- APVO N/A
- OMH $23.07
- P/E Ratio
- APVO N/A
- OMH N/A
- Revenue Growth
- APVO N/A
- OMH 117.53
- 52 Week Low
- APVO $1.07
- OMH $0.59
- 52 Week High
- APVO $298.00
- OMH $5.10
- Technical
- Relative Strength Index (RSI)
- APVO 27.92
- OMH 23.06
- Support Level
- APVO $1.39
- OMH $0.79
- Resistance Level
- APVO $1.54
- OMH $1.57
- Average True Range (ATR)
- APVO 0.09
- OMH 0.10
- MACD
- APVO -0.03
- OMH -0.04
- Stochastic Oscillator
- APVO 3.06
- OMH 6.28
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.